A C-terminal domain targets the Pseudomonas aeruginosa cytotoxin ExoU to the plasma membrane of host cells.

Infection and Immunity
Shira D P RabinAlan R Hauser

Abstract

ExoU, a phospholipase injected into host cells by the type III secretion system of Pseudomonas aeruginosa, leads to rapid cytolytic cell death. Although the importance of ExoU in infection is well established, the mechanism by which this toxin kills host cells is less clear. To gain insight into how ExoU causes cell death, we examined its subcellular localization following transfection or type III secretion/translocation into HeLa cells. Although rapid cell lysis precluded visualization of wild-type ExoU by fluorescence microscopy, catalytically inactive toxin was readily detected at the periphery of HeLa cells. Biochemical analysis confirmed that ExoU was targeted to the membrane fraction of transfected cells. Visualization of ExoU peptides fused with green fluorescent protein indicated that the domain responsible for this targeting was in the C terminus of ExoU, between residues 550 and 687. Localization to the plasma membrane occurred within 1 h of expression, which is consistent with the kinetics of cytotoxicity. Together, these results indicate that a domain between residues 550 and 687 of ExoU targets this toxin to the plasma membrane, a process that may be important in cytotoxicity.

References

Mar 1, 1991·Molecular & General Genetics : MGG·M W GanalS D Tanksley
May 24, 1991·Science·A LupasJ Stock
Jan 1, 1990·Annual Review of Biochemistry·M Takeichi
Oct 5, 1990·Journal of Molecular Biology·S F AltschulD J Lipman
Sep 1, 1997·Nucleic Acids Research·S F AltschulD J Lipman
Jan 14, 1998·Molecular Microbiology·D W Frank
Jun 10, 1998·Microbiology and Molecular Biology Reviews : MMBR·C J Hueck
Jun 25, 1998·Infection and Immunity·T SawaJ P Wiener-Kronish
Sep 1, 1999·Proceedings of the National Academy of Sciences of the United States of America·D ZhouJ E Galán
Sep 24, 1999·The Journal of Clinical Investigation·K KurahashiJ P Wiener-Kronish
Aug 2, 2000·Proceedings of the National Academy of Sciences of the United States of America·S J JurisJ E Dixon
Aug 10, 2000·Molecular Microbiology·K J PedersonJ T Barbieri
May 24, 2001·The Journal of Infectious Diseases·A Roy-BurmanJ P Wiener-Kronish
Jun 22, 2001·Journal of Bacteriology·V Finck-Barbançon, D W Frank
Oct 9, 2001·European Journal of Biochemistry·H J HirschbergM R Egmond
Nov 5, 2003·The Journal of Biological Chemistry·Rebecca KrallJoseph T Barbieri
Dec 10, 2003·The Journal of Cell Biology·Lorraine D HernandezJorge E Galán
Dec 19, 2003·Nucleic Acids Research·Ivica LetunicPeer Bork

❮ Previous
Next ❯

Citations

Aug 15, 2009·Nature Reviews. Microbiology·Alan R Hauser
Apr 17, 2013·Nature Reviews. Microbiology·Stuart W Hicks, Jorge E Galán
Dec 12, 2007·The Journal of Experimental Medicine·Fayyaz S SutterwalaRichard A Flavell
Mar 28, 2009·Critical Care Medicine·Jeffrey L VeesenmeyerJordi Rello
Jan 27, 2010·Infection and Immunity·Maureen H Diaz, Alan R Hauser
May 4, 2010·Journal of Bacteriology·M Sayeedur RahmanAbdu F Azad
Jan 26, 2010·Journal of Bacteriology·Katherine M SchmalzerDara W Frank
Jan 12, 2013·Current Protein & Peptide Science·Marlies GalleRudi Beyaert
Feb 13, 2015·Critical Care : the Official Journal of the Critical Care Forum·Teiji SawaJeanine P Wiener-Kronish
Nov 11, 2009·Clinica Chimica Acta; International Journal of Clinical Chemistry·Marc A BensonDara W Frank
May 20, 2008·Microbial Pathogenesis·Maria-Cristina PlotkowskiPatrícia T Bozza
Dec 30, 2006·Trends in Microbiology·Izabela SitkiewiczJames M Musser
Mar 13, 2014·Cellular Microbiology·Carolina Diettrich Mallet de LimaAlessandra Mattos Saliba
Jan 27, 2009·Current Opinion in Microbiology·Joanne Engel, Priya Balachandran
Jun 17, 2009·Cell Host & Microbe·Jorge E Galán
Nov 21, 2018·Journal of Bacteriology·Maxx H TessmerDara W Frank
Feb 22, 2007·The Journal of Biological Chemistry·Yue ZhangJoseph T Barbieri
Dec 19, 2016·The Journal of General and Applied Microbiology·Hayron CanchigniaHumberto Prieto

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.